Novartis is collaborating with Microsoft to apply machine learning to medicinal chemistry — part of an effort to leverage AI to bring treatments to patients more efficiently.

Pneumatic tube systems have existed for 150+ years and have transported everything from telegrams to aircraft parts. Now they’re being used in our labs.

In Wendi Yajnik’s quest to find new technologies that could transform medicine, relationships are priority No. 1.

Researchers from industry and academia will leverage new chemistry to hit difficult drug targets.

Novartis drug hunters leverage machine learning and automation to power a faster, smarter way to navigate to new drugs.

Novartis researchers are collaborating with tech startup PathAI to search for hidden information in pathology slides.

After 40 years of working in information technology, Jim Barrington took a partial retirement from his job as Novartis’ chief information officer and started looking for new ways to apply his skills.

Ann Aerts has stared death in the eye. The head of the non-profit Novartis Foundation lost colleagues when she was serving as an emergency medicine physician on a medical mission in a dangerously unstable country.

Explaining Chagas disease through the stories of patients in Latin America.

AI is already accelerating drug discovery and health delivery. It has great potential to accelerate research, workflow and processes, and even reengineer entire healthcare systems. But what challenges must be addressed first? Shahram Ebadollahi and Ann Aerts share the ideas they discussed at the Intelligent Health summit in Basel this week.

The cause of a rare, inherited, often fatal kidney disease in many patients remained elusive for years, despite multiple attempts to solve the mystery. Then in 2012, a team of researchers cracked some of the unsolved cases in just six weeks.

Novartis researchers use automation to rapidly identify starting points for new drugs.